Shopping Cart
- Remove All
- Your shopping cart is currently empty
Selicrelumab (RG-7876) is an antibody targeting CD40 with potential anti-tumor activity that induces changes in the tumor microenvironment in patients with resectable pancreatic cancer and may be used to study pancreatic cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $193 | In Stock | |
5 mg | $473 | In Stock | |
10 mg | $679 | In Stock | |
25 mg | $987 | In Stock | |
50 mg | $1,380 | In Stock |
Description | Selicrelumab (RG-7876) is an antibody targeting CD40 with potential anti-tumor activity that induces changes in the tumor microenvironment in patients with resectable pancreatic cancer and may be used to study pancreatic cancer. |
Alias | RO-7009789, RO7009789, RG-7876, RG7876 |
Cas No. | 1622140-49-1 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.